Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 16/20 | 0.44 |
| ▸ | WDR77 | Q9BQA1 | 10/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | METTL3 | Q86U44 | 6/20 | 0.39 |
| ▸ | ADK | P55263 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23892321 | 0.90 | PRMT5 (0.43) | PRMT5WDR77BCHEMETTL3ADK | |
| SCHEMBL23892611 | 0.90 | PRMT5 (0.44) | PRMT5WDR77BCHEMETTL3ADK | |
| SCHEMBL23892232 | 0.89 | PRMT5 (0.44) | PRMT5WDR77BCHEMETTL3ADK | |
| SCHEMBL25950438 | 0.84 | PRMT5 (0.33) | PRMT5WDR77BCHE | |
| SCHEMBL23892355 | 0.84 | PRMT5 (0.33) | PRMT5WDR77BCHE | |
| SCHEMBL25951705 | 0.82 | PRMT5 (0.46) | PRMT5WDR77METTL3ADK | |
| SCHEMBL23892650 | 0.82 | PRMT5 (0.46) | PRMT5WDR77METTL3ADK | |
| SCHEMBL18572412 | 0.81 | PRMT5 (0.66) | PRMT5WDR77METTL3 | |
| SCHEMBL23892442 | 0.80 | PRMT5 (0.44) | PRMT5WDR77BCHEMETTL3ADK | |
| SCHEMBL23892699 | 0.80 | PRMT5 (0.49) | PRMT5WDR77METTL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219496-A1 | NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | JANSSEN Pharmaceutica NV (BE) | 2023-08-02 | — | — | EP | disclosed |
| EP-3341368-B1 | NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-10-06 | — | — | EP | disclosed |